Shandra R. Day
The Ohio State University Wexner Medical Center(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Antifungal resistance and susceptibility, Fungal Infections and Studies, Clostridium difficile and Clostridium perfringens research, COVID-19 Clinical Research Studies
Most-Cited Works
- → Quantification of the Adenylate Cyclase Toxin of Bordetella pertussisIn Vitroand during Respiratory Infection(2013)68 cited
- → Caenorhabditisis a metazoan host forLegionella(2009)66 cited
- → Tricarboxylic Acid Cycle-Dependent Synthesis of Staphylococcus aureus Type 5 and 8 Capsular Polysaccharides(2010)50 cited
- → An Infectious Diseases Physician-Led Antimicrobial Stewardship Program at a Small Community Hospital Associated With Improved Susceptibility Patterns and Cost-Savings After the First Year(2015)31 cited
- In vitro antimicrobial activity of diethyldithiocarbamate and dimethyldithiocarbamate against methicillin-resistant Staphylococcus.(1987)
- → Disulfide Bond Oxidoreductase DsbA2 of Legionella pneumophila Exhibits Protein Disulfide Isomerase Activity(2013)25 cited
- → Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature(2014)16 cited
- → Legionella pneumophila utilizes a single‐player disulfide‐bond oxidoreductase system to manage disulfide bond formation and isomerization(2014)15 cited
- → Early Administration of Remdesivir and Intensive Care Unit Admission in Hospitalized Pregnant Individuals With Coronavirus Disease 2019 (COVID-19)(2022)15 cited
- → Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections(2021)12 cited